# US 2026/0117205 A1 · Recombinant yeast and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0117205 A1
- Document ID: US20260117205A1
- Status: Published application
- Kind: A1
- Application number: 18/706,827
- Filed: 2023-02-21
- Published: 2026-04-30
- Earliest claimed: 2022-03-11
- Assignees: Shandong Henglu Biotech. Co., Ltd.
- Applicants: Shandong Henglu Biotech. Co., Ltd.
- Inventors: Xu FANG; Fengyi LI; Lijuan HAN; Wencheng YIN
- Web page: https://patentgrep.com/patent/US20260117205A1

## CPC

- C12N 9/1051: {Hexosyltransferases (2.4.1)}
- C12P 7/06: Ethanol, i.e. non-beverage
- C12P 19/00: Preparation of compounds containing saccharide radicals (ketoaldonic acids C12P7/58)
- C12P 19/04: Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- C12P 19/18: produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
- C12P 19/26: Preparation of nitrogen-containing carbohydrates
- C12Y 204/01056: Lipopolysaccharide N-acetylglucosaminyltransferase (2.4.1.56)
- C12Y 204/01129: Peptidoglycan glycosyltransferase (2.4.1.129)
- C12Y 204/0115: N-Acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (2.4.1.150)
- C12Y 204/01155: Alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase (2.4.1.155)
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- Y02E 50/10: Biofuels, e.g. bio-diesel
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

A recombinant yeast for producing lacto-N-triose, and an application thereof, belonging to the bioengineering field wherein the recombinant yeast includes an amino acid sequence of a β-N-acetylglucosaminyl transferase and a coding nucleic acid sequence thereof, and/or a disruption of a marker gene. The technical solution of the recombinant yeast has the advantages of easy availability of raw materials, simple and feasible method, suitable for industrial production, and excellent application prospects.

## Claims

### Claim 1

An enzyme for catalyzing the production of lacto-N-triose II (LNTII), classified according to the Carbohydrate-Active Enzymes (CAZy) database as belonging to the glycoside hydrolase family 28, wherein the enzyme is a β-N-acetylglucosaminyl transferase.

### Claim 2 (depends on 1)

The enzyme according to claim 1, comprising an amino acid sequence having at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, and possessing the activity to catalyze the production of LNTII.

### Claim 3 (depends on 1)

The enzyme according to claim 1, wherein the enzyme is a β-N-acetylglucosaminyl transferase originating from Neisseria meningitidis; and
an amino acid sequence of the β-N-acetylglucosaminyl transferase is as set forth in SEQ ID NO:1, or comprises an amino acid sequence as set forth in SEQ ID NO: 1, or has at least 70% amino acid sequence identity with SEQ ID NO: 1, or comprises an amino acid sequence with at least 70% sequence identity with SEQ ID NO:1.

### Claim 4 (depends on 1)

The enzyme according to claim 1, wherein the enzyme is a β-N-acetylglucosaminyl transferase originating from Helicobacter pylori; and
an amino acid sequence of the β-N-acetylglucosaminyl transferase is as set forth in SEQ ID NO:2, or comprises an amino acid sequence as set forth in SEQ ID NO: 2, or has at least 70% amino acid sequence identity with SEQ ID NO:2, or comprises an amino acid sequence with at least 70% sequence identity with SEQ ID NO:2.

### Claim 5 (depends on 1)

The enzyme according to claim 1, wherein the enzyme is a β-N-acetylglucosaminyl transferase originating from Salmonella enterical; an amino acid sequence of the β-N-acetylglucosaminyl transferase is as set forth in SEQ ID NO:3, or has at least 70% amino acid sequence identity with SEQ ID NO:3, or comprises an amino acid sequence as set forth in SEQ ID NO:3, or comprises an amino acid sequence with at least 70% sequence identity with SEQ ID NO:3.

### Claim 6 (depends on 1)

A recombinant yeast for producing lacto-N-triose II (LNTII), comprising an amino acid sequence of β-N-acetylglucosaminyl transferase as claimed in claim 1 and a nucleic acid sequence encoding the amino acid sequence.

### Claim 7 (depends on 6)

The recombinant yeast according to claim 6, further comprising a marker gene with disruption;
the disruption refers to a partial disruption of the marker gene;
the marker gene comprises a nucleotide sequence encoding an amino acid sequence of entire or partial of β-galactosidase, and
the amino acid sequence having at least 50%, 51%, 52%, 53%, 54%, 55%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to SEQ ID NO:4 and/or SEQ ID NO:5.

### Claim 8 (depends on 6)

The recombinant yeast according to claim 6, wherein the LNTII is produced while concurrently fermenting the recombinant yeast to produce ethanol.

### Claim 9 (depends on 6)

A method for producing LNTII by using a recombinant yeast according to claim 6;
comprises: (a) culturing the recombinant yeast cells in a fermentable culture medium under suitable conditions to produce LNTII; and (b) recovering the LNTII.

### Claim 10 (depends on 6)

An ultraviolet-induced mutant of a recombinant yeast as claimed in claim 6, having further enhanced capability for synthesizing LNTII.

### Claim 11 (depends on 6)

The recombinant yeast according to claim 6, wherein the recombinant yeast with yeast as a host cell, wherein the yeast is selected from genera Candida, Hansenula, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces, or Yarrowi.

### Claim 12 (depends on 11)

The recombinant yeast according to claim 11, wherein the host cell is selected from Saccharomyces cerevisiae cell, Kluyveromyces lactis cell, Kluyveromyces marxianus cell, Yarrowia lipolytica cell, Rhodotorula graminis cell, and Saccharomyces pastorianus cell.

### Claim 13 (depends on 6)

The recombinant yeast according to claim 6, wherein the recombinant yeast is recombinant Kluyveromyces lactis or Kluyveromyces marxianus.

### Claim 14 (depends on 7)

The recombinant yeast according to claim 7, wherein the recombinant yeast is recombinant Kluyveromyces lactis or recombinant Kluyveromyces marxianus; and the recombinant yeast comprises at least one marker gene with disruption, and comprises an amino acid sequence of the marker, and a nucleic acid sequence encoding the marker.

### Claim 15 (depends on 8)

The recombinant yeast according to claim 8, wherein a method for constructing the recombinant yeast comprises:
(a) cultivating a parental strain;
(b) disrupting a marker gene in the parental strain mentioned in (a);
(c) introducing an enzyme capable of producing LNTII; and
optionally comprising:
(d) isolating the recombinant yeast.

### Claim 16 (depends on 9)

The method according to claim 9, wherein the fermentable culture medium is an aqueous solution comprising lactose and/or glucose and/or fructose and/or sucrose and/or galactose.

### Claim 17 (depends on 9)

The method according to claim 9, wherein a temperature for culturing the recombinant yeast is 15-60° C.

### Claim 18 (depends on 9)

The method according to claim 9, wherein the fermentable culture medium also comprises inorganic salts and/or trace elements, and the inorganic salts and/or trace elements are selected from one or more of the combinations of dipotassium phosphate, magnesium sulfate, ammonium sulfate, manganese sulfate, and potassium sulfate.

### Claim 19 (depends on 9)

The method according to claim 9, wherein a final concentration of the inorganic salts or trace elements is 3-7 mM.

### Claim 20 (depends on 9)

The method according to claim 9, wherein the LNTII is obtained after separation and purification by a method of adding activated carbon.
